Original Research
Published on 25 Jul 2022
Effect of depression disorder on the efficacy and quality of life of first-line chemotherapy combined with immunotherapy in oncogene-driver negative NSCLC patients
in Thoracic Oncology
![Effect of depression disorder on the efficacy and quality of life of first-line chemotherapy combined with immunotherapy in oncogene-driver negative NSCLC patients](https://www.frontiersin.org/files/myhome article library/772102/772102_Thumb_400.jpg)
- 1,556 views
- 1 citation